Edan Instruments, Inc.

Shenzhen Stock Exchange 300206.SZ

Edan Instruments, Inc. Return on Assets (ROA) for the year ending December 31, 2023: 10.00%

Edan Instruments, Inc. Return on Assets (ROA) is 10.00% for the year ending December 31, 2023, a -4.06% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Edan Instruments, Inc. Return on Assets (ROA) for the year ending December 31, 2022 was 10.42%, a -7.79% change year over year.
Edan Instruments, Inc. Return on Assets (ROA) for the year ending December 31, 2021 was 11.30%, a -60.92% change year over year.
Edan Instruments, Inc. Return on Assets (ROA) for the year ending December 31, 2020 was 28.91%, a 228.27% change year over year.
Edan Instruments, Inc. Return on Assets (ROA) for the year ending December 31, 2019 was 8.81%, a 37.04% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

Shenzhen Stock Exchange: 300206.SZ

Edan Instruments, Inc.

CEO	Mr. Hao Zhang
IPO Date	April 21, 2011
Location	China
Headquarters	Jinsha Community
Employees	2,695
Sector	Healthcare
Industries Medical Instruments 3D Printing Biotechnology Hardware & Electronics Pharmaceuticals Telehealth

Description

Edan Instruments, Inc. engages in the research, development, manufacture, and sale of medical equipment worldwide. The company offers diagnostic electrocardiograph (ECG) products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as vital signs, transport, and central monitoring systems, as well as high acuity cares, acute and sub-acute cares, telemetry, and pulse oximetry products; and obstetrics and gynecology products comprising fetal and maternal monitoring systems, fetal telemetry systems, ultrasonic doppler systems, and video colposcopes. It also provides ultrasound imaging systems that include color doppler ultrasound and B/W digital ultrasound systems; and in-vitro diagnostics, which comprise hematology analyzers. In addition, the company offers point-of-care testing systems, including blood gas and chemistry, magnetic immunoassay, and colloidal gold-labeled immunoassay analyzers; and veterinary ultrasound, ECG, ABG, and monitoring products. Edan Instruments, Inc. is headquartered in Shenzhen, the People's Republic of China.

Key trends

Past 5 years